practolol has been researched along with Angor Pectoris in 75 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Following an initial dose response study, metoprolol, a selective beta1-receptor blocking agent, was compared with equipotent dosages of propanolol in a double blind cross-over study, including exercise tolerance tests, on fourteen patients with angina pectoris." | 9.04 | An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris. ( Besterman, EM; Comerford, MB, 1976) |
| "Three beta1-selective beta-blocker (metoprolol, practolol and H 87/07) were compared in 29 patients with stable angina pectoris." | 9.04 | A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris. ( Keyriläinen, O; Uusitalo, A, 1978) |
| "The value of practolol in the treatment of angina pectoris was studied in three groups of patients by means of different methods." | 9.04 | Clinical investigations into the effects of practolol in angina pectoris. ( Chlebus, H; Jarecki, M; Kadzielawa, R; Waclawek, J, 1977) |
| "In thirteen patients with coronary insufficiency and angina pectoris the therapeutic effects of verapamil, 80 mg three times/day and practolol, 100 mg three times/day, were compared and tested against placebo in a double-blind cross-over fashion." | 9.04 | Double-blind comparison of verapamil and practolol in the treatment of angina pectoris. ( Fagher, B; Persson, S; Svensson, SE, 1977) |
| "Forty-two patients with angina pectoris have completed a randomized, double-blind trial comparing tolamolol 100 mg and 200 mg with propranolol 80 mg, practolol 100 mg, and placebo, all given three times a day." | 9.04 | Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. ( Atkinson, L; Jackson, G; Oram, S, 1975) |
| "Six patients developed intestinal obstruction from sclerosing peritonitis due to practolol." | 7.65 | Sclerosing peritonitis due to practolol. ( Jackson, BT; Thompson, RP, 1977) |
| "The case is described of a patient who presented with the characteristic symptoms and signs of sclerosing peritonitis due to practolol therapy." | 7.65 | Sclerosing peritonitis and practolol therapy. ( Cook, AI; Foy, P, 1976) |
| "Practolol was withdrawn from the market in 1975." | 5.26 | [Sclerosing peritonitis and practolol (author's transl)]. ( Hess, T; Stucki, P, 1977) |
| "Following an initial dose response study, metoprolol, a selective beta1-receptor blocking agent, was compared with equipotent dosages of propanolol in a double blind cross-over study, including exercise tolerance tests, on fourteen patients with angina pectoris." | 5.04 | An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris. ( Besterman, EM; Comerford, MB, 1976) |
| "Three beta1-selective beta-blocker (metoprolol, practolol and H 87/07) were compared in 29 patients with stable angina pectoris." | 5.04 | A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris. ( Keyriläinen, O; Uusitalo, A, 1978) |
| "The value of practolol in the treatment of angina pectoris was studied in three groups of patients by means of different methods." | 5.04 | Clinical investigations into the effects of practolol in angina pectoris. ( Chlebus, H; Jarecki, M; Kadzielawa, R; Waclawek, J, 1977) |
| "3 years, with stable angina pectoris earlier treated with beta-blockers, were investigated with standardized exercise tests to evaluate the action of nifedipine alone and in combination with a beta-blocker." | 5.04 | Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study. ( Ekelund, LG; Orö, L, 1979) |
| "In thirteen patients with coronary insufficiency and angina pectoris the therapeutic effects of verapamil, 80 mg three times/day and practolol, 100 mg three times/day, were compared and tested against placebo in a double-blind cross-over fashion." | 5.04 | Double-blind comparison of verapamil and practolol in the treatment of angina pectoris. ( Fagher, B; Persson, S; Svensson, SE, 1977) |
| "Forty-two patients with angina pectoris have completed a randomized, double-blind trial comparing tolamolol 100 mg and 200 mg with propranolol 80 mg, practolol 100 mg, and placebo, all given three times a day." | 5.04 | Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. ( Atkinson, L; Jackson, G; Oram, S, 1975) |
| "Six patients developed intestinal obstruction from sclerosing peritonitis due to practolol." | 3.65 | Sclerosing peritonitis due to practolol. ( Jackson, BT; Thompson, RP, 1977) |
| "The case is described of a patient who presented with the characteristic symptoms and signs of sclerosing peritonitis due to practolol therapy." | 3.65 | Sclerosing peritonitis and practolol therapy. ( Cook, AI; Foy, P, 1976) |
| " Acute dose-response studies showed that all five drugs improved exercise tolerance and reduced ST-segment depression, heart rate and blood pressure by a similar degree in comparison with a placebo (P less than 0." | 2.65 | Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. ( Davidson, C; Singleton, W; Taylor, SH; Thadani, U, 1979) |
| "Propranolol and practolol were tested in patients with repeated daily occurrence of spontaneous angina." | 2.64 | Treatment of spontaneous angina pectoris with beta blocking agents. A clinical, electrocardiographic, and haemodynamic appraisal. ( Fiorentini, C; Guazzi, M; Magrini, F; Olivari, MT; Polese, A, 1975) |
| " In the dosage used in both studies, practolol significantly improved the exercise tolerance and reduced the ischaemic manifestations." | 2.64 | Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease. ( Blouin, S; Dagenais, GR; Davies, RO; Marquis, Y; Moisan, A, 1976) |
| " After a two dose trial (Gillam and Prichard, 1966,) demonstrated a dose dependent anti-anginal effect, a log-dose response study demonstrated a progressive reduction in angina attacks as dosage was increased (Prichard and Gillam, 1971)." | 2.35 | Propranolol in the treatment of angina: a review. ( Prichard, BN, 1976) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| "Most of those liable to sudden death can be identified and it is possible that by the use of beta-adrenergic blocking or other antiarrhythmic drugs, by reducing the consumption of cigarettes and perhaps, by different therapies for hypertension, a substantial proportion of coronary deaths might be prevented or, at least, postponed." | 1.26 | Toward preventing coronary death from ventricular fibrillation. ( Julian, DG, 1976) |
| "Practolol was withdrawn from the market in 1975." | 1.26 | [Sclerosing peritonitis and practolol (author's transl)]. ( Hess, T; Stucki, P, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 75 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thadani, U | 2 |
| Davidson, C | 2 |
| Singleton, W | 2 |
| Taylor, SH | 2 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Chang, AR | 1 |
| Zamotaev, IP | 1 |
| Lozinskiĭ, LG | 1 |
| Sandomirskiĭ, BL | 1 |
| Maksimova, LN | 1 |
| Comerford, MB | 1 |
| Besterman, EM | 1 |
| Harry, JD | 1 |
| Fitzgerald, JD | 2 |
| Miller, HC | 1 |
| Westheim, AS | 1 |
| Christensen, CC | 1 |
| Kjekshus, J | 1 |
| Keyriläinen, O | 1 |
| Uusitalo, A | 1 |
| Wilkinson, RK | 1 |
| Fanchamps, A | 1 |
| Skegg, DC | 1 |
| Doll, R | 1 |
| Cochran, RE | 1 |
| Thomson, J | 1 |
| Fleming, K | 1 |
| McQueen, A | 1 |
| Sowton, E | 3 |
| Das Gupta, DS | 1 |
| Baker, I | 1 |
| Roy, P | 1 |
| Day, L | 1 |
| Folli, G | 1 |
| Radice, M | 1 |
| Beltrami, A | 1 |
| Potenza, S | 1 |
| Mariotti, G | 1 |
| Chlebus, H | 2 |
| Jarecki, M | 1 |
| Waclawek, J | 1 |
| Kadzielawa, R | 1 |
| Ekelund, LG | 1 |
| Orö, L | 1 |
| De'Thomatis, M | 1 |
| Falciola, N | 1 |
| Gallesio, R | 1 |
| Fagher, B | 1 |
| Persson, S | 1 |
| Svensson, SE | 1 |
| Amsterdam, EA | 2 |
| Mason, DT | 2 |
| Forrest, WA | 1 |
| Guazzi, M | 1 |
| Fiorentini, C | 1 |
| Polese, A | 1 |
| Magrini, F | 1 |
| Olivari, MT | 1 |
| Prichard, BN | 2 |
| Jackson, G | 1 |
| Atkinson, L | 1 |
| Oram, S | 1 |
| Julian, DG | 1 |
| Thompson, RP | 1 |
| Jackson, BT | 1 |
| Hess, T | 1 |
| Stucki, P | 1 |
| Rahi, AH | 1 |
| Chapman, CM | 1 |
| Garner, A | 1 |
| Wright, P | 1 |
| Cook, AI | 1 |
| Foy, P | 1 |
| Härich, B | 1 |
| Hassis, R | 1 |
| Immich, H | 1 |
| Jeschke, D | 1 |
| Kutscha, W | 1 |
| Schaumann, HJ | 1 |
| Stauch, M | 2 |
| Tschirdewahn, B | 1 |
| Bhatia, ML | 1 |
| Manjuran, RJ | 1 |
| Wasir, HS | 2 |
| Roy, SB | 1 |
| Farr, MJ | 1 |
| Wingate, JP | 1 |
| Shaw, JN | 1 |
| Windsor, WO | 1 |
| Durrein, F | 1 |
| Dyer, NH | 1 |
| Braam, JI | 1 |
| Reisma, K | 1 |
| Luiken, HC | 1 |
| van Hees, CA | 1 |
| Oeberius Kapteyn, JL | 1 |
| Henneveld, HE | 1 |
| Van Beugen, L | 1 |
| Hensen, A | 1 |
| Markiewicz, M | 1 |
| Gurry, JF | 1 |
| Cunningham, IG | 1 |
| Brooke, BN | 1 |
| Mikkelsen, HI | 1 |
| Jensen, HA | 1 |
| Wadskov, S | 1 |
| Sondergaard, J | 1 |
| Soimakallio, S | 1 |
| Vallinmäki, K | 1 |
| Lehmus, H | 1 |
| Marghescu, S | 1 |
| Fredhall, S | 1 |
| Dagenais, GR | 1 |
| Moisan, A | 1 |
| Marquis, Y | 1 |
| Davies, RO | 2 |
| Blouin, S | 1 |
| Hall, JA | 1 |
| Petch, MC | 1 |
| Brown, MJ | 1 |
| Brown, P | 1 |
| Baddeley, H | 1 |
| Read, AE | 1 |
| Davies, JD | 1 |
| McGarry, J | 1 |
| Offerhaus, L | 1 |
| Hughes, JL | 1 |
| DeMaria, AN | 1 |
| Zelis, R | 1 |
| Stroescu, V | 1 |
| Theodorini, S | 1 |
| Creţescu, R | 1 |
| Figini, A | 1 |
| De Ponti, C | 1 |
| Campolo, L | 1 |
| Armstrong, ML | 2 |
| Brand, D | 1 |
| Emmett, AJ | 1 |
| Hodge, JL | 1 |
| Kellaway, GS | 1 |
| Mestitz, P | 1 |
| Reefman, M | 1 |
| Wallace, DC | 1 |
| Judge, TG | 1 |
| Sen, PK | 1 |
| Mukerjee, AB | 1 |
| Bäckman, H | 1 |
| Martikainen, T | 1 |
| Ismail, SA | 1 |
| Waagstein, F | 1 |
| Hjalmarson, AC | 1 |
| Pauchant, M | 1 |
| Raftery, EB | 1 |
| Hubner, PJ | 1 |
| Ziady, GM | 1 |
| Lane, GK | 1 |
| Hardarson, T | 1 |
| Scales, B | 1 |
| Oakley, CM | 1 |
| Goodwin, JF | 1 |
| Król, W | 1 |
| Piwowarska, W | 1 |
| Bielecki, A | 1 |
| Bloch, A | 1 |
| Horvat, L | 1 |
| Datey, KK | 1 |
| Dalvi, CP | 1 |
| Härich, BK | 1 |
| Meier, J | 1 |
| Baranowski, E | 1 |
| Wagner, E | 1 |
| Yamasawa, I | 1 |
| Nohara, Y | 1 |
| Takayasu, M | 1 |
| Morimoto, M | 1 |
| Hiraide, S | 1 |
| Antonelli, G | 1 |
| Franchini, G | 1 |
| Cristallo, E | 1 |
| Cesaro, S | 1 |
| Limbourg, P | 1 |
| Just, H | 1 |
| Lang, KF | 1 |
| Schicketanz, KH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for practolol and Angor Pectoris
| Article | Year |
|---|---|
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Humans; Hy | 1978 |
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidofl | 1978 |
Propranolol in the treatment of angina: a review.
Topics: Alprenolol; Angina Pectoris; Dose-Response Relationship, Drug; Heart Rate; Humans; Isosorbide; Pract | 1976 |
The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectoris.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Anxiety Disorde | 1985 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Disea | 1974 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship | 1974 |
Beta-Blockers in the management of myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Volume; Coronary Disease; Depre | 1974 |
Vasodilators..
Topics: Adrenergic alpha-Antagonists; Aminophylline; Angina Pectoris; Bradycardia; Bronchial Diseases; Cereb | 1974 |
31 trials available for practolol and Angor Pectoris
| Article | Year |
|---|---|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Double-Blind Method; Exercise T | 1980 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Comparative evaluation of the clinical action of a series of beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Bronchi; Clinical Trials as Topi | 1976 |
An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Exercise Test; | 1976 |
Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Chronic Disease; Clinical T | 1976 |
A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Heart Rate; Humans; Metoprolol; Physic | 1978 |
[Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Humans; Hy | 1978 |
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as T | 1975 |
Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Clinical Trials | 1975 |
Clinical investigations into the effects of practolol in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Exercise Test; Female; | 1977 |
Effects of atenolol in angina.
Topics: Adult; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Huma | 1977 |
Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study.
Topics: Aged; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Dr | 1979 |
Double-blind comparison of verapamil and practolol in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Exercise Te | 1977 |
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Electroca | 1979 |
A double-blind clinical trial in angina pectoris. A comparison between oxprenolol, practolol and placebo.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Male; Middle Aged; Oxprenolol; Placebos; Practolo | 1975 |
Treatment of spontaneous angina pectoris with beta blocking agents. A clinical, electrocardiographic, and haemodynamic appraisal.
Topics: Angina Pectoris; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Dose-Re | 1975 |
Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Electrocard | 1975 |
Role of non-invasive methods in clinical evaluation of drugs in ischaemic heart disease.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Echoc | 1976 |
[Clinical studies on the effect of drugs used in the treatment of angina].
Topics: Adult; Aged; Amino Alcohols; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coumarins; E | 1975 |
Practolol--a cardioselective beta adrenergic blocking agents in the treatment of angina pectoris 'a double blind trial'.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Placebos; | 1975 |
Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart; Heart Function Test | 1976 |
Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart.
Topics: Albuterol; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Diseas | 1989 |
Comparative study of two beta-adrenergic blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma; Clinical Trials as Topic; Drug Evaluation; Dru | 1974 |
A multicentre trial of perhexiline maleate, beta-blocker and placebo in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alanine Transaminase; Angina Pectoris; Aspartate Aminotran | 1974 |
Clinical evaluation of practolol in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nitroglyc | 1974 |
Practolol in angina pectoris: a double-blind ergometric study.
Topics: Administration, Oral; Adult; Angina Pectoris; Clinical Trials as Topic; Exercise Test; Female; Heart | 1974 |
Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiomyopathy, Hypertrophic; Clinical Trials as Topic; Depr | 1973 |
Proceedings: A comparative study of perhexiline, beta-adrenergic blocking agents and placebos in the management of angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Perhexiline; Piperidines; Placebos; Practolol; Pr | 1973 |
[Evaluation of selective blocking of beta1-adrenergic receptors of heart in treatment of coronary disease (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middl | 1973 |
[Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Electroca | 1974 |
Warner oration. Advances in drug therapy of angina pectoris, with special reference to perhexiline maleate.
Topics: Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Perhexiline; Placebos; Practolol; V | 1974 |
36 other studies available for practolol and Angor Pectoris
| Article | Year |
|---|---|
Test and teach. Number twenty-one. Diagnosis: practolol induced sclerosing peritonitis.
Topics: Angina Pectoris; Female; Humans; Middle Aged; Peritoneum; Peritonitis; Practolol; Sclerosis | 1980 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
Prognosis of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Electrocardiography; Female; Follow-Up Studies; Humans | 1977 |
Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Cyclopentanes; Exercise Test; H | 1978 |
The role of long term beta-blockade after myocardial infarction: Paper 3.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Humans; Myocardial Infarction; Practolol; | 1978 |
Frequency of eye complaints and rashes among patients receiving practolol and propranolol.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Conjunctivitis; Corneal Diseases; Eczema; Female | 1977 |
The psoriasiform eruption induced by practolol.
Topics: Aged; Angina Pectoris; Atrial Fibrillation; Drug Eruptions; Female; Humans; Male; Middle Aged; Pract | 1975 |
Placebo effect in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Humans; M | 1978 |
Exercise testing and indirect assessment of myocardial oxygen consumption in evaluation of angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Electrocardiography; Evaluation Studies as | 1977 |
Toward preventing coronary death from ventricular fibrillation.
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Humans; Hyper | 1976 |
Sclerosing peritonitis due to practolol.
Topics: Angina Pectoris; Female; Humans; Intestinal Obstruction; Intestine, Small; Male; Middle Aged; Perito | 1977 |
[Sclerosing peritonitis and practolol (author's transl)].
Topics: Aged; Angina Pectoris; Female; Humans; Peritonitis; Practolol; Sclerosis; Time Factors | 1977 |
Pathology of practolol-induced ocular toxicity.
Topics: Aged; Angina Pectoris; Conjunctiva; Cornea; Epithelium; Eye; Eye Diseases; Female; Humans; Hypertens | 1976 |
Sclerosing peritonitis and practolol therapy.
Topics: Aged; Angina Pectoris; Female; Humans; Intestinal Obstruction; Peritonitis; Practolol; Sclerosis | 1976 |
Practolol and the nephrotic syndrome.
Topics: Aged; Angina Pectoris; Eye Diseases; Humans; Lupus Erythematosus, Systemic; Male; Nephrotic Syndrome | 1975 |
Fibrinous peritonitis: a complication of practolol therapy.
Topics: Angina Pectoris; Female; Humans; Intestinal Obstruction; Middle Aged; Peritonitis; Practolol; Tissue | 1975 |
[Sclerosing peritonitis following the use of practolol (Eraldin)].
Topics: Aged; Angina Pectoris; Female; Humans; Male; Middle Aged; Peritonitis; Practolol; Sclerosis | 1975 |
[Efficiency of the left heart ventricle in patients treated with practolol for angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Heart; Heart Ventricles; Humans; Male; Middle Aged; Practolol | 1975 |
Letter: beta-blockers and fibrinous peritonitis.
Topics: Aged; Angina Pectoris; Female; Humans; Intestinal Obstruction; Peritonitis; Pleural Effusion; Practo | 1975 |
[Skin and ocular lesions following long-term treatment with practolol (Eraldin)].
Topics: Adult; Aged; Angina Pectoris; Conjunctivitis; Female; Humans; Hypertension; Male; Middle Aged; Pract | 1975 |
Letter: Effect of new beta-adrenergic blocking agent.
Topics: Angina Pectoris; Atenolol; Humans; Practolol; Propanolamines; Statistics as Topic | 1975 |
[Practolol and sclerosing peritonitis].
Topics: Angina Pectoris; Female; Humans; Middle Aged; Peritonitis; Practolol | 1975 |
[Letter: Skin reactions due to practolol].
Topics: Angina Pectoris; Eye Diseases; Humans; Practolol; Skin Diseases | 1975 |
[Practolol (Eraldin)-induced peritoneal fibrosis?].
Topics: Aged; Angina Pectoris; Humans; Male; Peritoneal Diseases; Practolol | 1976 |
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).
Topics: Aged; Angina Pectoris; Barium Sulfate; Contrast Media; Diagnostic Techniques, Surgical; Duodenum; Fe | 1974 |
[Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Exercise Test; Humans; Isosorbide Dinitrate; Ma | 1974 |
Letter: Practolol and the eye.
Topics: Angina Pectoris; Female; Humans; Keratoconjunctivitis; Light; Methylcellulose; Middle Aged; Pain; Ph | 1974 |
Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol.
Topics: Acute Disease; Angina Pectoris; Blood Pressure; Cardiac Output; Electrocardiography; Heart Rate; Hum | 1974 |
Eramid for angina.
Topics: Angina Pectoris; Clofibrate; Drug Combinations; Humans; Practolol | 1974 |
[Use of Eraldine].
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Female; Humans; Male; Middle Aged; Practolol | 1974 |
Letter: cutaneous and ocular reactions to practolol.
Topics: Angina Pectoris; Antibodies, Antinuclear; Arrhythmias, Cardiac; Humans; Lupus Erythematosus, Systemi | 1974 |
[Comparative exercise tolerance studies in patients with coronary insufficiency receiving practolol (author's transl)].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiog | 1973 |
[Experimental studies on the cardio-selectivity of pindolol. Studies on healthy subjects, and patients with bronchitis and asthma].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Asthma; Bronchitis; Heart; Humans; Metaproterenol; Pindolol; | 1973 |
Continuous electrocardiographic recordings and serial changes of various serum enzymes in a patient with variant form of angina pectoris.
Topics: Alanine Transaminase; Angina Pectoris; Aspartate Aminotransferases; Creatine Kinase; Electrocardiogr | 1973 |
[Anti-anginous activity of the amiodarone-practolol combination].
Topics: Amiodarone; Angina Pectoris; Benzofurans; Drug Therapy, Combination; Female; Humans; Male; Middle Ag | 1973 |
[Beta-receptor blockade with practolol (author's transl)].
Topics: Angina Pectoris; Arteriosclerosis; Cardiac Output; Coronary Disease; Depression, Chemical; Heart; He | 1974 |